Hoarding disorder is often described as if it might be “caused” by a single errant chromosome, but the trajectory of genetic research, from early linkage ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared ...

A DNA index cutoff ≥1.10 delivered excellent discrimination for HHD (AUC 0.947) with high sensitivity and near-rule-out performance when negative (NPV 99.1%). Karyotype failure occurred in 25.2%, and ...

Clinicians should prioritize genetic testing for young children who show signs of intellectual disability (ID) or developmental delays, according to a new report from the American Academy of ...

Try these tests to evaluate your strength and cardiovascular fitness. Credit... Supported by By Hilary Achauer Photographs by Ashley Barker How do you know if you are fit? Or, at least, fit enough?

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...

The following is a summary of “Whole genome sequencing vs chromosomal microarray analysis in prenatal diagnosis,” published in the SEPTEMBER 2023 issue of Obstetrics and Gynecology by Hu, et al.

Chromosomal microarray analysis (CMA) provides an opportunity to understand genetic causes of congenital heart disease (CHD). The methods for describing cardiac phenotypes in patients with CMA ...